Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Cerilliant
US Department of Justice
QuintilesIMS
Fish and Richardson
Chubb
Chinese Patent Office
Express Scripts
Argus Health

Generated: May 24, 2018

DrugPatentWatch Database Preview

ALAWAY Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Alaway patents expire, and what generic alternatives are available?

Alaway is a drug marketed by Bausch And Lomb and is included in one NDA.

The generic ingredient in ALAWAY is ketotifen fumarate. There are five drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ketotifen fumarate profile page.
Drug patent expirations by year for ALAWAY
Medical Subject Heading (MeSH) Categories for ALAWAY
Synonyms for ALAWAY
(2E)-BUT-2-ENEDIOIC ACID; 2-(1-METHYLPIPERIDIN-4-YLIDENE)-6-THIATRICYCLO[8.4.0.0(3),?]TETRADECA-1(10),3(7),4,11,13-PENTAEN-8-ONE
(E)-but-2-enedioic acid;10-(1-methylpiperidin-4-ylidene)-5H-benzo[1,2]cyclohepta[2,4-b]thiophen-4-one
10H-Benzo(4,5)cyclohepta(1,2-b)thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (E)-2-butenedioate (1:1)
126939-14-8
34580-14-8
4-(1-Methyl-4-piperidylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one hydrogen fumarate
4-(1-methylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one fumarate
4,9-Dihydro-4-(1-methyl-4-piperidinylidene-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one fumarate
4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one fumarate (1:1)
4,9-Dihydro-4-(1-methylpiperidin-4-ylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophene-10-one fumarate
580K148
AB0013347
AB1009287
AC-7589
AK139144
AKOS008901371
AN-674
BCP0726000236
BCP9000812
butenedioic acid; ketotifen
C19H21NOS.C4H4O4
C23H23NO5S
CCG-101110
CCG-40319
CHEBI:31750
CHEMBL1633
CPD000058462
CS-1988
D01332
EINECS 252-100-0
EU-0100706
FT-0082715
fumaric acid; ketotifen
H904
HBD503WORO
HC 20,511 fumarate
HC-20511
HC-20511 fumarate
HMS1569K03
HMS1921A12
HMS2052O11
HMS2092G16
HMS2096K03
HMS2232K10
HMS2233C06
HMS3262M13
HMS3266D20
HMS500F13
HY-B0157A
J-019659
K 2628
K0048
KB-53037
Ketotifen (fumarate)
Ketotifen for peak identification, European Pharmacopoeia (EP) Reference Standard
KETOTIFEN FUMARATE
Ketotifen fumarate (JP17/USAN)
Ketotifen fumarate (Zaditor)
Ketotifen fumarate [USAN:JAN]
Ketotifen fumarate salt
Ketotifen fumerate
Ketotifen hydrogen fumarate
Ketotifen Hydrogen Fumarate 1.0 mg/ml in Methanol (as free base)
Ketotifen hydrogen fumarate, European Pharmacopoeia (EP) Reference Standard
KS-1206
LP00706
LS-33821
MFCD00079394
MLS000069701
MLS000758236
MLS001148200
MLS001401421
MolPort-003-666-315
NC00360
NCGC00094057-01
NCGC00094057-02
NCGC00094057-03
NCGC00094057-04
NCGC00094057-05
NCGC00261391-01
NSC-757415
NSC757415
Opera_ID_1952
Pharmakon1600-01500668
PL008605
Prestwick_743
REGID_for_CID_5282408
s2024
SAM001246984
SCHEMBL8809
SCHEMBL8810
SMR000058462
SMR000653460
SPECTRUM1500668
SR-01000075951
SR-01000075951-1
ST51053512
Tox21_500706
UNII-HBD503WORO
YNQQEYBLVYAWNX-WLHGVMLRSA-N
Zaditen
Zaditen (TN)

US Patents and Regulatory Information for ALAWAY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb ALAWAY ketotifen fumarate SOLUTION/DROPS;OPHTHALMIC 021996-001 Dec 1, 2006 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bausch And Lomb ALAWAY ketotifen fumarate SOLUTION/DROPS;OPHTHALMIC 021996-002 Feb 11, 2015 OTC Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Teva
Fuji
Moodys
Accenture
UBS
Express Scripts
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.